Related Experiment Video

Updated: Mar 8, 2026

Neuroimaging Field Methods Using Functional Near Infrared Spectroscopy NIRS Neuroimaging to Study Global Child Development: Rural Sub-Saharan Africa
08:10

Neuroimaging Field Methods Using Functional Near Infrared Spectroscopy NIRS Neuroimaging to Study Global Child Development: Rural Sub-Saharan Africa

Published on: February 2, 2018

15.7K

Assessment of a Clinical Pharmacy Activity in a Pediatric Inpatient Department in Cote D'ivoire

Danho Pascal Abrogoua1, César Pacôme Békégnran2, Bi Marius Gro3

  • 1Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmaceutical and Biological Sciences, Félix Houphouët-Boigny University, Abidjan, Cote d'Ivoire; Department of Clinical Pharmacology, Teaching Hospital of Cocody, Abidjan, Cote d'Ivoire.

Journal of Basic and Clinical Pharmacy
|January 21, 2017
PubMed

Insights

Pharmaceutical interventions in pediatric care significantly improve patient management. These interventions were highly accepted by physicians and demonstrated substantial clinical impact, preventing adverse drug events.

Area of Science:

  • Clinical Pharmacy
  • Pediatric Medicine
  • Drug Safety

Background:

  • Clinical pharmacy services enhance patient care and economic outcomes in pediatric inpatient settings.
  • Effective pharmaceutical interventions are crucial for optimizing pediatric treatment plans.

Purpose of the Study:

  • To evaluate the significance and impact of pharmaceutical interventions (PIs) in a pediatric hospital in Abidjan, Cote d'Ivoire.
  • To assess the relevance of PIs by analyzing physician acceptance and clinical impact.

Main Methods:

  • A cross-sectional, descriptive study was conducted from February to September 2014.
  • Drug-related problems (DRPs) and PIs were classified using the French Society of Clinical Pharmacy criteria.
  • PI relevance was determined by physician acceptance rates and assessed clinical impact scores (PI0-PI3).

Main Results:

  • 116 PIs were performed, primarily during patient record analysis (68.1%).
  • Key DRPs included noncompliance, overdose, and underdosing.
  • PIs focused on dose adjustments, administration accuracy, and therapeutic choices, with a high acceptance rate (94.8%).
  • Most PIs had significant (67.3%) or very significant (16.4%) clinical impact.

Conclusions:

  • Pharmaceutical interventions in this pediatric unit were highly relevant and effective.
  • PIs contributed to optimizing therapy and preventing iatrogenic events in hospitalized children.
Abstract

Keywords:
Cote d’Ivoiredrug-related probleminpatientpediatricspharmaceutical intervention

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

638

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
586
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
628
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
48